Leica Biosystems has announced a new strategic partnership with L7 Informatics, a pioneer in data unification and workflow orchestration for life sciences, to advance leading pathology informatics.
The collaboration centres on leveraging L7|ESP (Enterprise Science Platform) to power next-generation, AI-ready solutions from Leica Biosystems across the entire pathology laboratory workflow.
With siloed data systems, rising diagnostic demands, and a shrinking workforce slowing workflows and delaying critical diagnoses, pathology departments are under growing pressure. Fragmented data flow remains a key barrier to unlocking timely, actionable insights. This partnership addresses these challenges by integrating Leica Biosystems' advanced instrumentation with L7|ESP's modern digital infrastructure to automate and orchestrate processes across the entire pathology workflow. Together, they create a unified platform that enhances reproducibility, boosts operational efficiency, shortens time to diagnosis, and enables AI-driven decision support; essential capabilities as laboratories strive to meet the rising demand for faster, more accurate cancer diagnostics.
"Our partnership with Leica Biosystems represents the next stage of digital transformation in diagnostics," said Mark L Spencer, President and CEO of L7 Informatics. "Together, we're combining Leica Biosystems' leadership in pathology with L7's expertise in unified data and workflow orchestration to build the infrastructure required for the next decade of AI-enabled discovery and diagnosis. Our collaboration with Leica Biosystems underscores a shared commitment to our customers and partners, and to patients."
"This work builds on our more than 150-year heritage of pathology innovation and expertise across the laboratory workflow," said William Day, Vice President and General Manager, Advanced Staining Instruments at Leica Biosystems. "L7|ESP provides the foundation for our next-generation data connectivity and automation solutions, enabling unified data and automated, streamlined workflows across pathology laboratories. This powerful advancement empowers laboratory professionals to focus on the work - rather than the workflow - so they can deliver faster, more reliable results with greater ease and efficiency."
Under the partnership, Leica Biosystems is now integrating L7|ESP into its workflow development initiatives, with commercial product availability expected in early 2026.